Clinical Trials Sponsored by Guerbet

Total 117 results

Guerbet

Recruiting

Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas (GDX-44-016)

Brain Tumor, Recurrent | Brain Tumor, Primary

Italy, Hungary, Poland
Guerbet

Recruiting

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

Central Nervous System Diseases | Pediatric Disorder | Body Indication

Hungary, Bulgaria, Poland, United States
Guerbet

Completed

Cardiac Safety Evaluation of P03277

Healthy Volunteers

Belgium
Guerbet

Completed

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) (PROMISE)

Lesion in Body Region

Korea, Republic of, United States, Spain, France, Germany, Hungary, Bulgaria, Italy, Mexico, Poland, Ukraine
Guerbet

Completed

Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions

Healthy Volunteers | Brain Lesion

Belgium
Guerbet

Terminated

DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC (DCE-MRI)

Hepatocellular Carcinoma

Korea, Republic of
Guerbet

Completed

Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration (NSsaFe)

Renal Insufficiency

Korea, Republic of, United States, Argentina, Belgium, Colombia, France, Germany, Italy, Spain, Turkey, United Kingdom
Guerbet

Completed

Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

Renal Insufficiency

France, Belgium, Spain, Italy
Guerbet

Completed

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

Diagnostic Imaging

France
Guerbet

Recruiting

Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up

Oncology

Austria, France, Switzerland
Guerbet

Completed

Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis

Chronic Liver Disease | HepatoCellular Carcinoma

France
Guerbet

Completed

Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers

Pharmacokinetics

Japan
Guerbet

Completed

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) (PICTURE)

Blood Brain Barrier Defect | CNS Lesion

United States, Spain, Korea, Republic of, Taiwan, France, Hungary, Belgium, Germany, Italy, Mexico, Poland
Guerbet

Completed

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis (ACCREDIT)

Type 2 Diabetes Mellitus | Coronary Atherosclerosis

Korea, Republic of
Guerbet

Completed

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients

Pathological Processes

United States
Guerbet

Completed

Hepatic Xenetix-CT Perfusion

Hepatocellular Carcinoma

Germany, Switzerland, Korea, Republic of, Austria
Guerbet

Completed

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Magnetic Resonance Imaging

France, Austria, Hungary, Poland
Guerbet

Completed

Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

General Safety Profile of DOTAREM

Argentina, China, France, Spain, India, United Kingdom, Austria, Germany, Italy, Saudi Arabia
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Renal Disease

United States
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Guerbet

Completed

A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography

Arterial Occlusive Disease

Korea, Republic of
Guerbet

Not yet recruiting

Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination

Patient Participation
Guerbet

Completed

Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI

Pediatric Patients | Central Nervous System Indication | Body Indication

Bulgaria, Hungary, Poland, Slovakia, Ukraine
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Guerbet

Unknown

Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. (In-Live)

Hemangioendothelioma | Angiosarcoma | Congenital Hemangioma | Arteriovenous Malformation

India
Guerbet

Completed

Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function

Renal Insufficiency | Healthy Volunteers

Moldova, Republic of, Romania
Guerbet

Completed

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions (SENTIO)

Central Nervous System Diseases | Diagnostic Self Evaluation

United States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
Guerbet

Withdrawn

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (SHERLOC)

Renal Insufficiency | Nephrogenic Systemic Fibrosis

United States
Guerbet

Completed

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Contrast-enhanced MRI With Dotarem
Guerbet

Completed

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

MR Mammography With Dotarem
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Renal Artery Stenosis

United States
Guerbet

Completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT)

Coronary Artery Disease

Spain, France, Germany, Italy, Switzerland
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Guerbet

Completed

DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

Peripheral Arterial Disease

France
Guerbet

Completed

A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography

Diagnostic Imaging

Austria, France
Yale University
Guerbet

Completed

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Liver Cancer

United States
Loyola University
Guerbet

Unknown

Evaluation of Gadoterate in Patients With Decreased Kidney Function

Renal Dysfunction

United States
University of Chicago
Guerbet

Completed

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Fibroadenoma

United States
Virginia Commonwealth University
Guerbet

Withdrawn

A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney Disease (Zero-AKI)

Coronary Artery Disease | Acute Kidney Injury | Percutaneous Coronary Intervention

United States
Samsung Medical Center
Guerbet

Completed

Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy

Non-small Cell Lung Cancer

Korea, Republic of
Guerbet
Bracco Imaging S.p.A.

Recruiting

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

CNS Lesion | Lesion in Body Region

Japan
Johns Hopkins University
Guerbet

Not yet recruiting

High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment

Myocardial Fibrosis

United States
University of Washington
Guerbet

Withdrawn

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Malignant Neoplasm in the Head and Neck | Metastatic Malignant Neoplasm in the Head and Neck

United States
University Hospital, Montpellier
Guerbet

Recruiting

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion (LIDA-BII)

Carcinoma, Hepatocellular

France
Phoenix Children's Hospital
Guerbet

Completed

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

Brain Diseases

United States
University Hospital, Grenoble
Guerbet

Terminated

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease (PROSPER)

Meniere's Disease

France

3

Subscribe